Primary record
4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E)-
- 库存
- 8,639 克
- 纯度
- 98.8 %
- CAS
- 128794-94-5
化合物标识与属性
- CAS
- 128794-94-5
- PubChem CID
- 5281078
- SMILES
- CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)O
- Canonical SMILES
- COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2
名称与同义词
- mycophenolate mofetil
- CellCept
- Myfenax
- 128794-94-5
- myclausen
- Munoloc
- Mycophenylate mofetil
- Mycophenolatemofetil
- TM-MMF
- Arzip
- mycophenolic acid
- Mycophenolate
- Linfonex
- MYHIBBIN
- Cellcept (TN)
- Mofetil mycophenolate
- Mycophenolatmofetil
- MMF CellCept(TM)
- Mycophenolate mofetil Teva
- 115007-34-6
- RS 61443
- RS-61443
- mycophenolate-mofetil
- ME-MPA
- Mofetil, Mycophenolate
- MycophenolateMofetilMMF
- AC1NQXZW
- Mycophenolic acid morpholinoethyl ester
- RefChem:55675
- Mycophenolate Mofetil-d4
- C23H31NO7
- Mycophenolate mofetil HCl
- CHEBI:8764
- Mycophenolate mofetil CRS
- DTXSID3023340
- MFCD00867568
- Mycophenolate mofetil [USAN]
- D04FBR
- D0MS5I
- HSDB 7436
- UNII-9242ECW6R0
- AC1Q6O6X
- SCHEMBL4195
- DTXCID103340
- 9242ECW6R0
- CHEMBL1456
- MLS003915627
- MLS004774133
- MLS006011929
- Mycophenolate mofetil (CellCept)
- NSC-724229
- NSC-758905
- 2-(4-morpholinyl)ethyl ester
- RTGDFNSFWBGLEC-SYZQJQIISA-N
- GTPL6831
- Mycophenolate mofetil [USAN:USP]
- orb1300896
- orb1310798
- MYCOPHENOLATE MOFETIL 1G
- SCHEMBL29378681
- CHEBI:93612
- HY-B0199R
- Mycophenolate Mofetil (Standard)
- Mycophenolate mofetil(CellCept)/
- AOB5505
- Mycophenolate mofetil (JAN/USP)
- Mycophenolate mofetil hydrochloride
- NSC724229
- R-99 (inflammation), Pharmagene
- GLXC-06676
- HMS2090A03
- HMS5079C12
- Mycophenolate mofetil (JAN/USAN)
- Mycophenolate Mofetil Impurity 32
- Pharmakon1600-01504567
- MYCOPHENOLATE MOFETIL [JAN]
- R-99 (ocular disease), Allergan
- ACT01993
- ALBB-027273
- HY-B0199
- MYCOPHENOLATE MOFETIL 100MG
- Mycophenolate Mofetil (Rs-61443)
- MYCOPHENOLATE MOFETIL [HSDB]
- R-99 (immune disorders), Asterand
- Tox21_111686
- ABP000539
- AR-1J6939
- BBF-03983
- BBL029073
- BDBM50248299
- C23-H31-N-O7
- EBC-11251
- MSK001604
- MYCOPHENOLATE MOFETIL [VANDF]
- NSC758905
- RW2729
- s1501
- STL146382
- ZINC21297660
- MYCOPHENOLATE MOFETIL [MART.]
- R-99
- AKOS005720900
- MYCOPHENOLATE MOFETIL [USP-RS]
- MYCOPHENOLATE MOFETIL [WHO-DD]
- R-99 (immune disorders), Pharmagene
- Tox21_111686_1
- AC-1562
- ACN-048189
- BCP9000969
- CCG-213315
- CID5281078
- CS-2135
- DB00688
- FM26106
- KS-1209
- NSC 724229
- NSC 758905
- RS61443
- MYCOPHENOLATE MOFETIL [EMA EPAR]
- Mycophenolate mofetil, >=98% (HPLC)
- RS-61443-190
- NCGC00159459-02
- NCGC00159459-03
- NCGC00159459-04
- AJ-78121
- AN-14797
- AN-33289
- BC225627
- BC283431
- BM164622
- LS-15013
- LS-75572
- Mycophenolate mofetil - Bio-X trade mark
- SC-19049
- SMR002544686
- SMR004703518
- SY057966
- MYCOPHENOLATE MOFETIL [ORANGE BOOK]
- 2-(morpholin-4-yl)ethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoate
- 2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate
- AB0125583
- J378.713C
- LS-172272
- MYCOPHENOLATE MOFETIL [EP MONOGRAPH]
- Mycophenolate Mofetil EPCRS (Y0000489)
- TL8000648
- A4336
- CAS-128794-94-5
- FT-0631127
- FT-0652331
- FT-0672560
- M2387
- MYCOPHENOLATE MOFETIL [USP MONOGRAPH]
- Mycophenolate mofetil for peak identification
- MYCOPHENOLIC ACID 2-(4-MORPHOLINYL)ETHYL ESTER
- NS00006994
- R3925
- ST24035026
- SW219893-1
- 4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E)-
- 2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
- A10613
- C07908
- D00752
- J90063
- Mycophenolate mofetil 100 microg/mL in Acetonitrile
- SBI-0653417.0001
- W18801
- (E)-2-Morpholinoethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate
- AB01274794-01
- AB01274794-02
- AB01274794_03
- AB01274794_04
- EN300-1705962
- MMF
- Mycop henolic acid 2-(4-morpholinyl)ethyl ester
- Mycophenolate mofetil for peak identification CRS
- 007M346
- A803280
- A805863
- A888971
- SR-05000001485
- 2-morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate
- 4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (E)-
- I01-0898
- I06-1947
- Q4567614
- SR-05000001485-1
- SR-05000001485-2
- BRD-K92428153-001-01-0
- BRD-K92428153-001-04-4
- BRD-K92428153-001-05-1
- CellCept, RS 61443, TM-MMF, Mycophenolate mofetil
- Z2568665233
- 1076198-64-5
- 140401-05-4
- 2-morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-hex-4-enoate
- 2-Morpholinoethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate
- Mycophenolate mofetil =98.0% (by HPLC, titration analysis)
- Mycophenolate mofetil for Peak Identification CRS (Y0000519)
- MYCOPHENOLIC ACID 2-(4-MORPHOLINYL)ETHYL ESTER [MI]
- 1132748-21-0
- 2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate
- 24280-93-1
- Mycophenolate mofetil, European Pharmacopoeia (EP) Reference Standard
- Mycophenolate mofetil, United States Pharmacopeia (USP) Reference Standard
- Mycophenolate mofetil for peak identification, European Pharmacopoeia (EP) Reference Standard
- Mycophenolate mofetil, 98%, a reversible inhibitor of (IMPDH1/2) - 100MG 100mg
- Mycophenolate Mofetil, Pharmaceutical Secondary Standard; Certified Reference Material
- (1s,3r,4s)-2-amino-9-[4-(benzyloxy)-3-(benzyloxymethyl)-2-methylidene-cyclopentyl]-3h-purin-6-one
- (4E)-6-(1,3-DIHYDRO-4-HYDROXY-6-METHOXY-7-METHYL-3-OXO-5-ISOBENZOFURANYL)4-HEXENOIC ACID 4-METHYL-2-(4-MORPHOLINYL)ETHYL ESTER
- (E)-4-Methyl-6-[(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxoisobenzofuran)-5-yl]-4-hexenoic acid 2-morpholinoethyl ester
- (E)-6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic Acid 2-(4-Morpholinyl)ethyl Ester
- (E)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methyl-4-hexenoic acid 2-morpholinoethyl ester
- (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-4-hexenoic acid 2-(4-morpholinyl)ethyl ester
- (E)-6-[(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxoisobenzofuran)-5-yl]-4-methyl-4-hexenoic acid 2-morpholinoethyl ester
- 1306-01-0
- 2-(4-MORPHOLINO)ETHYL (E)-6-(1,3-DIHYDRO-4-HYDROXY-6-METHOXY-7-METHYL)-3-OXO-5-ISOBENZOFURANYL)-4-METHYL-4-HEXENOATE
- 2-(4-Morpholinyl)ethyl (E)-6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate
- 2-(Morpholin-4-yl)ethyl (4E)-6-(4-hydroxy-6-methoxy-7methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex4-enoate
- 2-morpholin-4-ylethyl (E)-6-(6-methoxy-7-methyl-4-oxidanyl-3-oxidanylidene-1H-2-benzofuran-5-yl)-4-methyl-hex-4-enoate
- 2-morpholin-4-ylethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoate
- 2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
- 4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E)
- 4-Hexenoic acid,3-dihydro-4-hydroxy-6-methoxy-7-methyl -3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E)
- 4-HEXENOIC ACID,6-(1,3-DIHYDRO-4-HYDROXY-6-METHOXY-7-METHYL-3-OXO-5-ISOBENZOFURANYL)-4-METHYL-,2-(4-MORPHOLINYL)ETHYL ESTER
- 4-HEXENOIC ACID,6-(1,3-DIHYDRO-4-HYDROXY-6-METHOXY-7-METHYL-3-OXO-5-ISOBENZOFURANYL)-4-METHYL-,2-(4-MORPHOLINYL)ETHYL ESTER, (4E)-
- 4-Hexenoic acid,6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-,2-(4-morpholinyl)ethyl ester,(4E)-
- 6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid 2-(4-morpholinyl)ethyl ester
- 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-4-hexenoic acid 2-(4-morpholinyl)ethyl ester
- 6-[(7-hydroxy-5-methoxy-4-methyl-1-oxo-3h-isobenzofuran-6-yl)]-4-methyl-hex-4-enoicacid2-morpholinoethylester
- 627-027-6
- morpholinoethyl (E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate
- Morpholinoethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)- 4-methylhex-4-enoate
- Morpholinoethyl E-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate
- Morpholinoethyl E-6-(1,3-dihydro-4-hydroxy-6-methoxy-7methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate